SynthesisVirology journal2019

Sofosbuvir-based regimen is safe and effective for hepatitis C infected patients with stage 4-5 chronic kidney disease: a systematic review and meta-analysis.

Mingshu Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.